Hydrogen sulphide and the kidney: Important roles in renal physiology and pathogenesis and treatment of kidney injury and disease

Nitric Oxide - Biology and Chemistry

Volumn 46, Issue , 2015, Pages 55-65

  Lobb, I ^a   Sonke, E ^a   Aboalsamh, G ^a   Sener, A ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Hydrogen sulphide; Renal disease; Renal physiology

Indexed keywords

CISPLATIN; GENTAMICIN; HYDROGEN SULFIDE;

APOPTOSIS; BLOOD VESSEL CALCIFICATION; CHRONIC KIDNEY DISEASE; COLD ISCHEMIA; CRUSH SYNDROME; DIABETIC NEPHROPATHY; END STAGE RENAL DISEASE; GLOMERULOSCLEROSIS; HYPERGLYCEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INFLAMMATION; KIDNEY; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; MORBIDITY; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; URETER OBSTRUCTION; ANIMAL; DRUG EFFECTS; HUMAN; KIDNEY DISEASES; METABOLISM;

MAMMALIA;

ANIMALS; HUMANS; HYDROGEN SULFIDE; KIDNEY; KIDNEY DISEASES;

EID: 84924787960     PISSN: 10898603     EISSN: 10898611     Source Type: Journal    
DOI: 10.1016/j.niox.2014.10.004     Document Type: Review

References (141)

1. K. Abe, and H. Kimura The possible role of hydrogen sulfide as an endogenous neuromodulator J. Neurosci 16 3 1996 1066 1071
2. R. Hosoki, N. Matsuki, and H. Kimura The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide Biochem. Biophys. Res. Commun 237 3 1997 527 531
3. Y.H. Liu, C.D. Yan, and J.S. Bian Hydrogen sulfide: a novel signaling molecule in the vascular system J. Cardiovasc. Pharmacol 58 6 2011 560 569
4. M. Xia, L. Chen, R.W. Muh, P.L. Li, and N. Li Production and actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys J. Pharmacol. Exp. Ther 329 3 2009 1056 1062
5. E. Lowicka, and J. Beltowski Hydrogen sulfide (H2S) - the third gas of interest for pharmacologists Pharmacol. Rep 59 1 2007 4 24
6. J.W. Gai, W. Wahafu, H. Guo, M. Liu, X.C. Wang, and Y.X. Xiao Further evidence of endogenous hydrogen sulphide as a mediator of relaxation in human and rat bladder Asian J. Androl 15 5 2013 692 696
7. M. Magierowski, K. Jasnos, S. Kwiecien, and T. Brzozowski Role of hydrogen sulfide in the physiology of gastrointestinal tract and in the mechanism of gastroprotection Postepy Hig. Med. Dosw. (Online) 67 2013 150 156
8. B. Srilatha, P.G. Adaikan, L. Li, and P.K. Moore Hydrogen sulphide: a novel endogenous gasotransmitter facilitates erectile function J. Sex. Med 4 5 2007 1304 1311
9. M. Whiteman, S. Le Trionnaire, M. Chopra, B. Fox, and J. Whatmore Emerging role of hydrogen sulfide in health and disease: critical appraisal of biomarkers and pharmacological tools Clin. Sci. (Lond.) 121 11 2011 459 488
10. J.T. Hancock, and M. Whiteman Hydrogen sulfide and cell signaling: team player or referee? Plant Physiol. Biochem 78C 2014 37 42
11. A.K. Mustafa, M.M. Gadalla, N. Sen, S. Kim, W. Mu, and S.K. Gazi H2S signals through protein S-sulfhydration Sci. Signal 2 96 2009 ra72
12. O. Kabil, and R. Banerjee Redox biochemistry of hydrogen sulfide J. Biol. Chem 285 29 2010 21903 21907
13. M. Fu, W. Zhang, L. Wu, G. Yang, H. Li, and R. Wang Hydrogen sulfide (H2S) metabolism in mitochondria and its regulatory role in energy production Proc. Natl. Acad. Sci. U.S.A. 109 8 2012 2943 2948
14. C. Szabo Hydrogen sulphide and its therapeutic potential Nat. Rev. Drug Discov 6 11 2007 917 935
15. J.W. Elrod, J.W. Calvert, J. Morrison, J.E. Doeller, D.W. Kraus, and L. Tao Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function Proc. Natl. Acad. Sci. U.S.A. 104 39 2007 15560 15565
16. Y. Gao, X. Yao, Y. Zhang, W. Li, K. Kang, and L. Sun The protective role of hydrogen sulfide in myocardial ischemia-reperfusion-induced injury in diabetic rats Int. J. Cardiol 152 2 2011 177 183
17. I. Lobb, A. Mok, Z. Lan, W. Liu, B. Garcia, and A. Sener Supplemental hydrogen sulphide protects transplant kidney function and prolongs recipient survival after prolonged cold ischaemia-reperfusion injury by mitigating renal graft apoptosis and inflammation Br. J. Urol. Int 110 11 Pt C 2012 E1187 95
18. P.M. Snijder, E. van den Berg, M. Whiteman, S.J. Bakker, H.G. Leuvenink, and H. van Goor Emerging role of gasotransmitters in renal transplantation Am. J. Transplant 13 12 2013 3067 3075
19. M.H. Stipanuk, and P.W. Beck Characterization of the enzymatic capacity for cysteine desulphhydration in liver and kidney of the rat Biochem. J. 206 1982 267 277
20. J.D. House, M.E. Brosnan, and J.T. Brosnan Characterization of homocysteine metabolism in the rat kidney Biochem. J. 328 Pt 1 1997 287 292
21. N. Nagahara, T. Ito, H. Kitamura, and T. Nishino Tissue and subcellular distribution of mercaptopyruvate sulfurtransferase in the rat: confocal laser fluorescence and immunoelectron microscopic studies combined with biochemical analysis Histochem. Cell Biol 110 3 1998 243 250
22. J. Yamamoto, W. Sato, T. Kosugi, T. Yamamoto, T. Kimura, and S. Taniguchi Distribution of hydrogen sulfide (H(2)S)-producing enzymes and the roles of the H(2)S donor sodium hydrosulfide in diabetic nephropathy Clin. Exp. Nephrol 17 1 2013 32 40
23. I. Ishii, N. Akahoshi, X.N. Yu, Y. Kobayashi, K. Namekata, and G. Komaki Murine cystathionine gamma-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression Biochem. J. 381 Pt 1 2004 113 123
24. N. Li, L. Chen, R.W. Muh, and P.L. Li Hyperhomocysteinemia associated with decreased renal transsulfuration activity in Dahl S rats Hypertension 47 6 2006 1094 1100
25. M. Lu, Y.H. Liu, H.S. Goh, J.J. Wang, Q.C. Yong, and R. Wang Hydrogen sulfide inhibits plasma renin activity J. Am. Soc. Nephrol 21 6 2010 993 1002
26. H. Xue, P. Yuan, J. Ni, C. Li, D. Shao, and J. Liu H(2)S inhibits hyperglycemia-induced intrarenal renin-angiotensin system activation via attenuation of reactive oxygen species generation PLoS ONE 8 9 2013 e74366
27. P. Yuan, H. Xue, L. Zhou, L. Qu, C. Li, and Z. Wang Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide Nephrol. Dial. Transplant 26 7 2011 2119 2126
28. H.J. Lee, M.M. Mariappan, D. Feliers, R.C. Cavaglieri, K. Sataranatarajan, and H.E. Abboud Hydrogen sulfide inhibits high glucose-induced matrix protein synthesis by activating AMP-activated protein kinase in renal epithelial cells J. Biol. Chem 287 7 2012 4451 4461
29. M.A. Aminzadeh, and N.D. Vaziri Downregulation of the renal and hepatic hydrogen sulfide (H2S)-producing enzymes and capacity in chronic kidney disease Nephrol. Dial. Transplant 27 2 2012 498 504
30. E. D'Araio, N. Shaw, A. Millward, A. Demaine, M. Whiteman, and A. Hodgkinson Hydrogen sulfide induces heme oxygenase-1 in human kidney cells Acta Diabetol 51 1 2014 155 157
31. J. Beltowski Hypoxia in the renal medulla: implications for hydrogen sulfide signaling J. Pharmacol. Exp. Ther 334 2 2010 358 363
32. K.R. Olson Hydrogen sulfide as an oxygen sensor Clin. Chem. Lab. Med 51 3 2013 623 632
33. R.F. Furchgott Role of endothelium in responses of vascular smooth muscle Circ. Res 53 5 1983 557 573
34. R. Wang Signaling pathways for the vascular effects of hydrogen sulfide Curr. Opin. Nephrol. Hypertens 20 2 2011 107 112
35. G. Yang, L. Wu, B. Jiang, W. Yang, J. Qi, and K. Cao H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase Science 322 5901 2008 587 590
36. E. Zavaczki, V. Jeney, A. Agarwal, A. Zarjou, M. Oros, and M. Katko Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle cells Kidney Int 80 7 2011 731 739
37. E. van den Berg, A. Pasch, W.H. Westendorp, G. Navis, E.J. Brink, and R.O. Gans Urinary sulfur metabolites associate with a favorable cardiovascular risk profile and survival benefit in renal transplant recipients J. Am. Soc. Nephrol 25 6 2014 1303 1312
38. X. Zhao, L.K. Zhang, C.Y. Zhang, X.J. Zeng, H. Yan, and H.F. Jin Regulatory effect of hydrogen sulfide on vascular collagen content in spontaneously hypertensive rats Hypertens. Res 31 8 2008 1619 1630
39. S. Kundu, S.B. Pushpakumar, A. Tyagi, D. Coley, and U. Sen Hydrogen sulfide deficiency and diabetic renal remodeling: role of matrix metalloproteinase-9 Am. J. Physiol. Endocrinol. Metab 304 12 2013 E1365 E1378
40. U. Sen, P. Basu, O.A. Abe, S. Givvimani, N. Tyagi, and N. Metreveli Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure Am. J. Physiol. Renal Physiol 297 2 2009 F410 F419
41. G. Andresdottir, S.J. Bakker, H.P. Hansen, H.H. Parving, and P. Rossing Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetes Diabet. Med 30 5 2013 563 566
42. B.D. Humphreys Targeting pericyte differentiation as a strategy to modulate kidney fibrosis in diabetic nephropathy Semin. Nephrol 32 5 2012 463 470
43. D.A. Zhao, J. Liu, Q. Huang, and Z.M. Han Change in plasma H2S level and therapeutic effect of H2S supplementation in tubulointerstitial fibrosis among rats with unilateral ureteral obstruction Zhongguo Dang Dai Er Ke Za Zhi 15 10 2013 903 908
44. K. Song, F. Wang, Q. Li, Y.B. Shi, H.F. Zheng, and H. Peng Hydrogen sulfide inhibits the renal fibrosis of obstructive nephropathy Kidney Int 85 6 2014 1318 1329
45. K.J. Jung, H.S. Jang, J.I. Kim, S.J. Han, J.W. Park, and K.M. Park Involvement of hydrogen sulfide and homocysteine transsulfuration pathway in the progression of kidney fibrosis after ureteral obstruction Biochim. Biophys. Acta 1832 12 2013 1989 1997
46. C. van Guldener Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering? Nephrol. Dial. Transplant 21 5 2006 1161 1166
47. L. Pin-Lan, Y. Fan, and L. Ningjun Hyperhomocysteinemia: association with renal transsulfuration and redox signaling in rats Clin. Chem. Lab. Med 45 12 2007 1688 1693
48. U. Sen, C. Munjal, N. Qipshidze, O. Abe, R. Gargoum, and S.C. Tyagi Hydrogen sulfide regulates homocysteine-mediated glomerulosclerosis Am. J. Nephrol 31 5 2010 442 455
49. L. Chang, B. Geng, F. Yu, J. Zhao, H. Jiang, and J. Du Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats Amino Acids 34 4 2008 573 585
50. U. Sen, S. Givvimani, O.A. Abe, E.D. Lederer, and S.C. Tyagi Cystathionine beta-synthase and cystathionine gamma-lyase double gene transfer ameliorate homocysteine-mediated mesangial inflammation through hydrogen sulfide generation Am. J. Physiol. Cell Physiol 300 1 2011 C155 C163
51. U. Sen, P.B. Sathnur, S. Kundu, S. Givvimani, D.M. Coley, and P.K. Mishra Increased endogenous H2S generation by CBS, CSE, and 3MST gene therapy improves ex vivo renovascular relaxation in hyperhomocysteinemia Am. J. Physiol. Cell Physiol 303 1 2012 C41 C51
52. H.F. Galley Can acute renal failure be prevented? J. R. Coll. Surg. Edinb 45 1 2000 44 50
53. C.A. Naughton Drug-induced nephrotoxicity Am. Fam. Physician 78 6 2008 743 750
54. M.A. Perazella Renal vulnerability to drug toxicity Clin. J. Am. Soc. Nephrol 4 7 2009 1275 1283
55. N.P. Singh, A. Ganguli, and A. Prakash Drug-induced kidney diseases J. Assoc. Physicians India 51 2003 970 979
56. R.A. Zager Pathogenetic mechanisms in nephrotoxic acute renal failure Semin. Nephrol 17 1 1997 3 14
57. S.Y. Kim, and A. Moon Drug-induced nephrotoxicity and its biomarkers Biomol. Ther. (Seoul) 20 3 2012 268 272
58. B. Rosenberg, L. Vancamp, and T. Krigas Inhibition of cell division in escherichia coli by electrolysis products from a platinum electrode Nature 205 1965 698 699
59. M. Candelaria, A. Garcia-Arias, L. Cetina, and A. Duenas-Gonzalez Radiosensitizers in cervical cancer. Cisplatin and beyond Radiat. Oncol 1 2006 15
60. C.W. Helm, and J.C. States Enhancing the efficacy of cisplatin in ovarian cancer treatment - could arsenic have a role J. Ovarian. Res 2 2009 2
61. N.P. Campbell, and H.L. Kindler Update on malignant pleural mesothelioma Semin. Respir. Crit. Care Med 32 1 2011 102 110
62. N. Ismaili, M. Amzerin, and A. Flechon Chemotherapy in advanced bladder cancer: current status and future J. Hematol. Oncol 4 2011 35
63. I. Arany, and R.L. Safirstein Cisplatin nephrotoxicity Semin. Nephrol 23 5 2003 460 464
64. J.P. Ward Gamma-glutamyl transpeptidase. A sensitive indicator of renal ischaemic injury in experimental animals and renal homograft rejection in man Ann. R. Coll. Surg. Engl 57 5 1975 248 261
65. R.D. Wainford, R.J. Weaver, K.N. Stewart, P. Brown, and G.M. Hawksworth Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway Toxicology 249 2-3 2008 184 193
66. Y. Sadzuka, T. Shoji, and Y. Takino Mechanism of the increase in lipid peroxide induced by cisplatin in the kidneys of rats Toxicol. Lett 62 2-3 1992 293 300
67. L.M. Antunes, J.D. Darin, and M.D. Bianchi Protective effects of vitamin c against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dose-dependent study Pharmacol. Res 41 4 2000 405 411
68. R.H. Lee, J.M. Song, M.Y. Park, S.K. Kang, Y.K. Kim, and J.S. Jung Cisplatin-induced apoptosis by translocation of endogenous Bax in mouse collecting duct cells Biochem. Pharmacol 62 8 2001 1013 1023
69. M.S. Park, M. De Leon, and P. Devarajan Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways J. Am. Soc. Nephrol 13 4 2002 858 865
70. B. Zhang, G. Ramesh, C.C. Norbury, and W.B. Reeves Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells Kidney Int 72 1 2007 37 44
71. S.B. Howell, C.L. Pfeifle, W.E. Wung, R.A. Olshen, W.E. Lucas, and J.L. Yon Intraperitoneal cisplatin with systemic thiosulfate protection Ann. Intern. Med 97 6 1982 845 851
72. C.E. Pfeifle, S.B. Howell, R.D. Felthouse, T.B. Woliver, P.A. Andrews, and M. Markman High-dose cisplatin with sodium thiosulfate protection J. Clin. Oncol 3 2 1985 237 244
73. R.E. van Rijswijk, K. Hoekman, C.W. Burger, R.H. Verheijen, and J.B. Vermorken Experience with intraperitoneal cisplatin and etoposide and i.v. sodium thiosulphate protection in ovarian cancer patients with either pathologically complete response or minimal residual disease Ann. Oncol 8 12 1997 1235 1241
74. D.T. Dickey, Y.J. Wu, L.L. Muldoon, and E.A. Neuwelt Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels J. Pharmacol. Exp. Ther 314 3 2005 1052 1058
75. M.M. Jones, M.A. Basinger, and M.A. Holscher Thioether suppression of cisplatin nephrotoxicity in the rat Anticancer Res 11 1 1991 449 453
76. C. Dwivedi, A. Abu-Ghazaleh, and J. Guenther Effects of diallyl sulfide and diallyl disulfide on cisplatin-induced changes in glutathione and glutathione-S-transferase activity Anticancer Drugs 7 7 1996 792 794
77. J.P. Chiarandini Fiore, S.L. Fanelli, E.C. de Ferreyra, and J.A. Castro Diallyl disulfide prevention of cis-Diamminedichloroplatinum-induced nephrotoxicity and leukopenia in rats: potential adjuvant effects Nutr. Cancer 60 6 2008 784 791
78. A. Fard, A. Ahangarpour, M.K. Gharibnaseri, T. Jalali, I. Rashidi, and M. Ahmadzadeh Effects of hydrogen sulfide on oxidative stress, tnf-α level and kidney histological changes in cisplatin nephrotoxicity in rat J. Phys. Pharm. Adv 3 3 2013 57 65
79. V.P. Dam, J.L. Scott, A. Ross, and R.T. Kinobe Inhibition of cystathionine gamma-lyase and the biosynthesis of endogenous hydrogen sulphide ameliorates gentamicin-induced nephrotoxicity Eur. J. Pharmacol 685 1-3 2012 165 173
80. P. Balakumar, and A. Rohilla Thangathirupathi A. Gentamicin-induced nephrotoxicity: do we have a promising therapeutic approach to blunt it? Pharmacol. Res 62 3 2010 179 186
81. J. Pedraza-Chaverri, P.D. Maldonado, O.N. Medina-Campos, I.M. Olivares-Corichi, M.A. Granados-Silvestre, and R. Hernandez-Pando Garlic ameliorates gentamicin nephrotoxicity: relation to antioxidant enzymes Free Radic. Biol. Med 29 7 2000 602 611
82. J. Pedraza-Chaverri, A.E. Gonzalez-Orozco, P.D. Maldonado, D. Barrera, O.N. Medina-Campos, and R. Hernandez-Pando Diallyl disulfide ameliorates gentamicin-induced oxidative stress and nephropathy in rats Eur. J. Pharmacol 473 1 2003 71 78
83. S. Kalayarasan, P.N. Prabhu, N. Sriram, R. Manikandan, M. Arumugam, and G. Sudhandiran Diallyl sulfide enhances antioxidants and inhibits inflammation through the activation of Nrf2 against gentamicin-induced nephrotoxicity in Wistar rats Eur. J. Pharmacol 606 1-3 2009 162 171
84. P.D. Maldonado, M.E. Chanez-Cardenas, and J. Pedraza-Chaverri Aged garlic extract, garlic powder extract, S-allylcysteine, diallyl sulfide and diallyl disulfide do not interfere with the antibiotic activity of gentamicin Phytother. Res 19 3 2005 252 254
85. A. Otunctemur, E. Ozbek, M. Dursun, S. Sahin, H. Besiroglu, and O.D. Ozsoy Protective effect of hydrogen sulfide on gentamicin-induced renal injury Ren. Fail 36 6 2014 925 931
86. H.D. Francescato, E.C. Marin, Q. Cunha Fde, R.S. Costa, C.G. Silva, and T.M. Coimbra Role of endogenous hydrogen sulfide on renal damage induced by adriamycin injection Arch. Toxicol 85 12 2011 1597 1606
87. H.D.C. Francescato, F.Q. Cunha, R.S. Costa, F. Barbosa Júnior, M.A. Boim, and C.P. Arnoni Inhibition of hydrogen sulphide formation reduces cisplatin-induced renal damage Nephrol. Dial. Transplant 26 2 2011 479 488
88. H.D. Francescato, J.R. Chierice, E.C. Marin, F.Q. Cunha, R.S. Costa, and C.G. Silva Effect of endogenous hydrogen sulfide inhibition on structural and functional renal disturbances induced by gentamicin Braz. J. Med. Biol. Res 45 3 2012 244 249
89. R. Guo, K. Wu, J. Chen, L. Mo, X. Hua, and D. Zheng Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NFkappaB pathway in H9c2 cardiac cells Cell. Physiol. Biochem 32 6 2013 1668 1680
90. R. Guo, J. Lin, W. Xu, N. Shen, L. Mo, and C. Zhang Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells Int. J. Mol. Med 31 3 2013 644 650
91. B.A. Molitoris, J. Leiser, and M.C. Wagner Role of the actin cytoskeleton in ischemia-induced cell injury and repair Pediatr. Nephrol 11 6 1997 761 767
92. T.H. Kwon, J. Frokiaer, J.S. Han, M.A. Knepper, and S. Nielsen Decreased abundance of major Na(+) transporters in kidneys of rats with ischemia-induced acute renal failure Am. J. Physiol. Renal Physiol 278 6 2000 F925 F939
93. O. Kwon, W.J. Nelson, R. Sibley, P. Huie, J.D. Scandling, and D. Dafoe Backleak, tight junctions, and cell- cell adhesion in postischemic injury to the renal allograft J. Clin. Invest 101 10 1998 2054 2064
94. S.L. Ashworth, and B.A. Molitoris Pathophysiology and functional significance of apical membrane disruption during ischemia Curr. Opin. Nephrol. Hypertens 8 4 1999 449 458
95. H.R. Brady, and G.G. Singer Acute renal failure Lancet 346 8989 1995 1533 1540
96. J.M. Weinberg, M.A. Venkatachalam, N.F. Roeser, and I. Nissim Mitochondrial dysfunction during hypoxia/reoxygenation and its correction by anaerobic metabolism of citric acid cycle intermediates Proc. Natl. Acad. Sci. U.S.A. 97 6 2000 2826 2831
97. K. Zhao, G.M. Zhao, D. Wu, Y. Soong, A.V. Birk, and P.W. Schiller Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury J. Biol. Chem 279 33 2004 34682 34690
98. K.A. Nath, and S.M. Norby Reactive oxygen species and acute renal failure Am. J. Med 109 8 2000 665 678
99. C. Li, and R.M. Jackson Reactive species mechanisms of cellular hypoxia-reoxygenation injury Am. J. Physiol. Cell Physiol 282 2 2002 C227 C241
100. R.E. Ratych, R.S. Chuknyiska, and G.B. Bulkley The primary localization of free radical generation after anoxia/reoxygenation in isolated endothelial cells Surgery 102 2 1987 122 131
101. P. Li, D. Nijhawan, I. Budihardjo, S.M. Srinivasula, M. Ahmad, and E.S. Alnemri Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade Cell 91 4 1997 479 489
102. W. Jassem, S.V. Fuggle, M. Rela, D.D. Koo, and N.D. Heaton The role of mitochondria in ischemia/reperfusion injury Transplantation 73 4 2002 493 499
103. K.A. Roebuck, L.R. Carpenter, V. Lakshminarayanan, S.M. Page, J.N. Moy, and L.L. Thomas Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF-kappaB J. Leukoc. Biol 65 3 1999 291 298
104. K.K. Donnahoo, D.R. Meldrum, R. Shenkar, C.S. Chung, E. Abraham, and A.H. Harken Early renal ischemia, with or without reperfusion, activates NFkappaB and increases TNF-alpha bioactivity in the kidney J. Urol 163 4 2000 1328 1332
105. H. Rabb, Y.M. O'Meara, P. Maderna, P. Coleman, and H.R. Brady Leukocytes, cell adhesion molecules and ischemic acute renal failure Kidney Int 51 5 1997 1463 1468
106. K.J. Kelly, W.W. Williams Jr., R.B. Colvin, and J.V. Bonventre Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury Proc. Natl. Acad. Sci. U.S.A. 91 2 1994 812 816
107. J.J. Friedewald, and H. Rabb Inflammatory cells in ischemic acute renal failure Kidney Int 66 2 2004 486 491
108. M. Heinzelmann, M.A. Mercer-Jones, and J.C. Passmore Neutrophils and renal failure Am. J. Kidney Dis 34 2 1999 384 399
109. S. Uchino, J.A. Kellum, R. Bellomo, G.S. Doig, H. Morimatsu, and S. Morgera Acute renal failure in critically ill patients: a multinational, multicenter study JAMA 294 7 2005 813 818
110. O. Liangos, R. Wald, J.W. O'Bell, L. Price, B.J. Pereira, and B.L. Jaber Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey Clin. J. Am. Soc. Nephrol 1 1 2006 43 51
111. R.H. Thompson, B.R. Lane, C.M. Lohse, B.C. Leibovich, A. Fergany, and I. Frank Every minute counts when the renal hilum is clamped during partial nephrectomy Eur. Urol 58 3 2010 340 345
112. D. Dragun, U. Hoff, J.K. Park, Y. Qun, W. Schneider, and F.C. Luft Prolonged cold preservation augments vascular injury independent of renal transplant immunogenicity and function Kidney Int 60 3 2001 1173 1181
113. A.K. Salahudeen, N. Haider, and W. May Cold ischemia and the reduced long-term survival of cadaveric renal allografts Kidney Int 65 2 2004 713 718
114. L.F. Hu, M. Lu, Z.Y. Wu, P.T. Wong, and J.S. Bian Hydrogen sulfide inhibits rotenone-induced apoptosis via preservation of mitochondrial function Mol. Pharmacol 75 1 2009 27 34
115. S. Jha, J.W. Calvert, M.R. Duranski, A. Ramachandran, and D.J. Lefer Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling Am. J. Physiol. Heart Circ. Physiol 295 2 2008 H801 H806
116. M.A. Mariggio, V. Minunno, S. Riccardi, R. Santacroce, P. De Rinaldis, and R. Fumarulo Sulfide enhancement of PMN apoptosis Immunopharmacol. Immunotoxicol 20 3 1998 399 408
117. A. Sivarajah, M. Collino, M. Yasin, E. Benetti, M. Gallicchio, and E. Mazzon Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R Shock 31 3 2009 267 274
118. M. Whiteman, J.S. Armstrong, S.H. Chu, S. Jia-Ling, B.S. Wong, and N.S. Cheung The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger J. Neurochem 90 3 2004 765 768
119. R.C. Zanardo, V. Brancaleone, E. Distrutti, S. Fiorucci, G. Cirino, and J.L. Wallace Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation FASEB J. 20 12 2006 2118 2120
120. P. Tripatara, N.S. Patel, M. Collino, M. Gallicchio, J. Kieswich, and S. Castiglia Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction Lab. Invest 88 10 2008 1038 1048
121. E.M. Bos, H.G. Leuvenink, P.M. Snijder, N.J. Kloosterhuis, J.L. Hillebrands, and J.C. Leemans Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury J. Am. Soc. Nephrol 20 9 2009 1901 1905
122. E.M. Bos, R. Wang, P.M. Snijder, M. Boersema, J. Damman, and M. Fu Cystathionine gamma-lyase protects against renal ischemia/reperfusion by modulating oxidative stress J. Am. Soc. Nephrol 24 5 2013 759 770
123. J.X. Zhu, M. Kalbfleisch, Y.X. Yang, R. Bihari, I. Lobb, and M. Davison Detrimental effects of prolonged warm renal ischaemia-reperfusion injury are abrogated by supplemental hydrogen sulphide: an analysis using real-time intravital microscopy and polymerase chain reaction BJU Int 110 11 Pt C 2012 E1218 E1227
124. I. Lobb, J. Zhu, W. Liu, A. Haig, Z. Lan, and A. Sener Hydrogen sulfide treatment ameliorates long-term renal dysfunction resulting from prolonged warm renal ischemia-reperfusion injury Can. Urol. Assoc. J. 8 5-6 2014 E413 E418
125. N. Shibuya, S. Koike, M. Tanaka, M. Ishigami-Yuasa, Y. Kimura, and Y Ogasawara A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells Nat. Commun 4 2013 1366
126. F. Simon, A. Scheuerle, M. Groger, B. Stahl, U. Wachter, and J. Vogt Effects of intravenous sulfide during porcine aortic occlusion-induced kidney ischemia/reperfusion injury Shock 35 2 2011 156 163
127. J.P. Hunter, S.A. Hosgood, M. Patel, R. Rose, K. Read, and M.L. Nicholson Effects of hydrogen sulphide in an experimental model of renal ischaemia-reperfusion injury Br. J. Surg 99 12 2012 1665 1671
128. M. Davison, I. Lobb, A. Lan, and A. Sener Hydrogen sulfide improves renal graft function and survival in a model of allogeneic renal transplantation Nitric Oxide 27 Suppl. 2 2012 S11
129. I. Lobb, M. Davison, D. Carter, Z. Lan, and A. Sener Hydrogen sulfide treatment reduces activation of ischemia-reperfusion injury-induced tissue inflammatory processes and resultant recipient adaptive immune response to donor tissue during allogeneic renal transplantation Nitric Oxide 31 Suppl. 2 2013 S60 S61
130. I. Lobb, M. Davison, Z. Lan, J. Jian, and A. Sener Hydrogen sulfide treatment improves graft function and survival following prolonged cold ischemia and allogeneic renal transplantation Nitric Oxide 39 Suppl. 1 2014 S25
131. C.M. Lee, J.T. Carter, E.J. Alfrey, N.L. Ascher, J.P. Roberts, and C.E. Freise Prolonged cold ischemia time obviates the benefits of 0 HLA mismatches in renal transplantation Arch. Surg 135 9 2000 1016 1019 discussion 1019-20
132. I. Quiroga, P. McShane, D.D. Koo, D. Gray, P.J. Friend, and S. Fuggle Major effects of delayed graft function and cold ischaemia time on renal allograft survival Nephrol. Dial. Transplant 21 6 2006 1689 1696
133. A.J. Matas, J.M. Smith, M.A. Skeans, B. Thompson, S.K. Gustafson, and M.A. Schnitzler OPTN/SRTR 2012 annual data report: kidney Am. J. Transplant 14 Suppl. 1 2014 11 44
134. A.C. Wells, L. Rushworth, S. Thiru, L. Sharples, C.J. Watson, and J.A. Bradley Donor kidney disease and transplant outcome for kidneys donated after cardiac death Br. J. Surg 96 3 2009 299 304
135. D.M. Summers, R.J. Johnson, J. Allen, S.V. Fuggle, D. Collett, and C.J. Watson Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: a cohort study Lancet 376 9749 2010 1303 1311
136. B. Dominguez-Gil, B. Haase-Kromwijk, H. Van Leiden, J. Neuberger, L. Coene, and P. Morel Current situation of donation after circulatory death in European countries Transpl. Int 24 7 2011 676 686
137. C. Gerstenkorn Non-heart-beating donors: renewed source of organs for renal transplantation during the twenty-first century World J. Surg 27 4 2003 489 493
138. T. Tojimbara, S. Fuchinoue, K. Iwadoh, I. Koyama, A. Sannomiya, and Y. Kato Improved outcomes of renal transplantation from cardiac death donors: a 30-year single center experience Am. J. Transplant 7 3 2007 609 617
139. M.G. Snoeijs, B. Winkens, M.B. Heemskerk, A.J. Hoitsma, M.H. Christiaans, and W.A. Buurman Kidney transplantation from donors after cardiac death: a 25-year experience Transplantation 90 10 2010 1106 1112
140. S.A. Hosgood, and M.L. Nicholson Hydrogen sulphide ameliorates ischaemia-reperfusion injury in an experimental model of non-heart-beating donor kidney transplantation Br. J. Surg 97 2 2010 202 209
141. 2S on renal protection during pulsatile perfusion Am. J. Transplant 11 Suppl. 2 2011 500